| Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis FJ Rios, ZG Zou, AP Harvey, KY Harvey, R Nosalski, P Anyfanti, ... Cardiovascular research 116 (3), 721-735, 2020 | 94 | 2020 |
| Annexin‐A1: the culprit or the solution? L Kelly, S McGrath, L Rodgers, K McCall, A Tulunay Virlan, F Dempsey, ... Immunology 166 (1), 2-16, 2022 | 26 | 2022 |
| Rheumatic disease: protease-activated receptor-2 in synovial joint pathobiology K McCulloch, S McGrath, C Huesa, L Dunning, G Litherland, A Crilly, ... Frontiers in endocrinology 9, 257, 2018 | 25 | 2018 |
| A close-up on the expanding landscape of CD21–/low B cells in humans I Gjertsson, S McGrath, K Grimstad, CA Jonsson, A Camponeschi, ... Clinical and Experimental Immunology 210 (3), 217-229, 2022 | 15 | 2022 |
| Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts M Corbet, MA Pineda, K Yang, A Tarafdar, S McGrath, R Nakagawa, ... PLoS Pathogens 17 (11), e1010069, 2021 | 13 | 2021 |
| Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint‐Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor–Induced … M Gatto, S Bjursten, CA Jonsson, ML Agelii, C Jonell, S McGrath, ... Arthritis & Rheumatology 75 (5), 856-863, 2023 | 4 | 2023 |
| Moderate exercise protects against joint disease in a murine model of osteoarthritis C Huesa, L Dunning, M Fegen, GJ Litherland, A Crilly, RJ Van‘T Hof, ... Frontiers in Physiology 13, 1065278, 2022 | 3 | 2022 |
| ES-62 suppression of arthritis reflects epigenetic rewiring of synovial fibroblasts to a joint-protective phenotype M Corbet, MA Pineda, K Yang, A Tarafdar, S McGrath, R Nakagawa, ... BioRxiv, 2020.10. 08.331942, 2020 | 3 | 2020 |
| Cartilage destruction in early rheumatoid arthritis patients correlates with CD21−/low double-negative B cells K Thorarinsdottir, S McGrath, K Forslind, ML Agelii, AKH Ekwall, ... Arthritis Research & Therapy 26 (1), 23, 2024 | 1 | 2024 |
| Professional antigen‐presenting Tbet+CD11c+ B cells correlate with bone destruction in untreated rheumatoid arthritis S McGrath, K Grimstad, K Thorarinsdottir, K Forslind, D Glinatsi, ... Arthritis & Rheumatology, 2024 | | 2024 |
| CD38 as a therapeutic target in pediatric Burkitt’s Lymphoma: insights from a comparative approach (Running title: Targeting CD38 in pediatric Burkitt's Lymphoma) K Kläsener, N Herrmann, L Håversen, T Sundell, M Sundqvist, ... | | 2024 |
| POS0322 CLINICAL DISEASE ACTIVITY INDEX REMISSION IN RHEUMATOID ARTHRITIS AT 6 MONTHS IS ASSOCIATED WITH HIGHER FREQUENCY OF TRANSITIONAL B CELLS AT DIAGNOSIS S Mcgrath, B Sundbeck, C Jonsson, K Thorarinsdottir, A Camponeschi, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 405-406, 2023 | | 2023 |
| The role of PAR2 in osteoblast differentiation versus function C Huesa, S McGrath, L Dunning, K McCulloch, KA McIntosh, J Cole, ... European Calcified Tissue Society Congress 2023, 2023 | | 2023 |
| CD21 (-) double-negative B cells correlate with joint damage in early, untreated rheumatoid arthritis K Thoransdottir, S McGrath, KN Grimstad, C Jonsson, T Sundell, LS Ottsjo, ... SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 50, 68-69, 2021 | | 2021 |
| OP0186 CHANGES IN CIRCULATING B CELL LEVELS AND IMMUNOPHENOTYPE ARE ASSOCIATED WITH DEVELOPMENT OF ARTHRITIS FOLLOWING TREATMENT WITH CHECKPOINT INHIBITORS M Gatto, S Bjursten, C Jonell, C Jonsson, S Mcgrath, A Rudin, M Levin, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 112-113, 2021 | | 2021 |
| The Role of PAR2 in the Myeloid Compartment and the Regulation of Osteoclastogenesis S McGrath University of Glasgow, 2019 | | 2019 |
| Protease Activated Receptor 2 (PAR2): A Novel Regulator of Osteoclastogenesis S Mcgrath, L Hultin, JC Lockhart, CS Goodyear JOURNAL OF BONE AND MINERAL RESEARCH 33, 379-380, 2018 | | 2018 |
| TRPM7 α-kinase Deficiency Causes Cardiovascular Inflammation and Fibrosis. FJ Rios, Z Zhi-guo, LL Camargo, AP Harvey, S Lacchini, P Anyfanti, ... Hypertension 72 (Suppl_1), A129-A129, 2018 | | 2018 |
| P018 Protease activated receptor 2 (PAR2) expression in the myeloid compartment impacts osteoclastogenesis S McGrath, L Hultin, JC Lockhart, CS Goodyear Annals of the Rheumatic Diseases 77 (Suppl 1), A21-A21, 2018 | | 2018 |
